Fertilità maschile e testosterone basso

1. Fertil Steril. 2013 Oct 2. pii: S0015-0282(13)03053-7. doi: 10.1016/j.fertnstert.2013.09.003. [Epub ahead of print]

Testosterone use in the male infertility population: prescribing patterns and
effects on semen and hormonal parameters.

Samplaski MK, Loai Y, Wong K, Lo KC, Grober ED, Jarvi KA.

Division of Urology, Department of Surgery, Mount Sinai Hospital, University of
Toronto, Toronto, Ontario, Canada.

OBJECTIVE: To analyze how frequently and why men presenting with infertility take testosterone (T) and if negative effects of T on semen parameters are reversed following cessation.
DESIGN: Analysis of a prospectively collected database.
SETTING: Male Infertility clinic.
PATIENT(S): Men presenting for fertility evaluation from 2008 to 2012.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): The frequency and reason for T use in the infertile male population, and semen and hormonal parameters while on T and following discontinuation.
RESULT(S): A total of 59/4,400 men (1.3%) reported taking T. T was prescribed by a variety of physicians, including endocrinologists (24%), general practitioners (17%), urologists (15%), gynecologists (5%), and reproductive endocrinologists (3%). Only one of the men admitted that he had obtained T from an illicit source. More than 82% of men were prescribed T for the treatment of hypogonadism, but surprisingly, 12% (7/59) were prescribed T to treat their infertility. While on
T, 88.4% of men were azoospermic, but by 6 months after T cessation, 65% of the men without other known causes for azoospermia recovered spermatogenesis.
CONCLUSION(S): In Canada, T was not commonly used by men presenting for fertility
investigation (1.3%). Close to 2/3 of infertile men using T recovered
spermatogenesis within 6 months of T discontinuation.

Copyright © 2013 American Society for Reproductive Medicine. Published by
Elsevier Inc. All rights reserved.

PMID: 24094422 [PubMed - as supplied by publisher]